Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Advaxis Inc (ADXS)  
$0.06 0.00 (0.00%) as of 4:30 Fri 6/3


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 66,230,000
Market Cap: 4.11(M)
Last Volume: 362,100 Avg Vol: 361,094
52 Week Range: $0.062 - $0.062
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,317,716 1,317,716
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 586
  Page 4 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Petit Robert Chief Scientific Officer   •       –      –    2017-04-28 4 A $8.56 $2,140 D/D 250 119,847     -
   O'connor Daniel Chief Executive Officer   •       •      –    2017-04-28 4 A $8.56 $2,987 D/D 349 297,091     -
   Bonstein Sara Chief Financial Officer   •       –      –    2017-04-28 4 A $8.56 $1,584 D/D 185 127,456     -
   O'connor Daniel Chief Executive Officer   •       •      –    2017-03-31 4 A $8.17 $2,982 D/D 365 296,742     -
   Petit Robert Chief Scientific Officer   •       –      –    2017-03-31 4 S $8.24 $20,221 D/D (2,454) 119,597     -
   Petit Robert Chief Scientific Officer   •       –      –    2017-03-31 4 A $8.17 $1,789 D/D 219 122,051     -
   Bonstein Sara Chief Financial Officer   •       –      –    2017-03-31 4 A $8.17 $1,585 D/D 194 127,271     -
   O'connor Daniel Chief Executive Officer   •       •      –    2017-02-28 4 D $8.79 $914 D/D (104) 296,377     -
   O'connor Daniel Chief Executive Officer   •       •      –    2017-02-28 4 A $8.79 $4,307 D/D 490 296,481     -
   Bonstein Sara Chief Financial Officer   •       –      –    2017-02-28 4 D $8.79 $536 D/D (61) 127,077     -
   Bonstein Sara Chief Financial Officer   •       –      –    2017-02-28 4 A $8.79 $2,312 D/D 263 127,138     -
   Petit Robert Chief Scientific Officer   •       –      –    2017-02-28 4 D $8.79 $457 D/D (52) 121,832     -
   Petit Robert Chief Scientific Officer   •       –      –    2017-02-28 4 A $8.79 $2,619 D/D 298 121,884     -
   Bonstein Sara Chief Financial Officer   •       –      –    2017-01-31 4 D $8.96 $502 D/D (56) 126,875     -
   Bonstein Sara Chief Financial Officer   •       –      –    2017-01-31 4 A $8.96 $2,240 D/D 250 126,931     -
   O'connor Daniel Chief Executive Officer   •       •      –    2017-01-31 4 D $8.96 $869 D/D (97) 295,991     -
   O'connor Daniel Chief Executive Officer   •       •      –    2017-01-31 4 A $8.96 $4,175 D/D 466 296,088     -
   Petit Robert Chief Scientific Officer   •       –      –    2017-01-31 4 D $8.96 $430 D/D (48) 121,586     -
   Petit Robert Chief Scientific Officer   •       –      –    2017-01-31 4 A $8.96 $2,527 D/D 282 121,634     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-12-30 4 D $7.16 $1,353 D/D (189) 126,681     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-12-30 4 A $0.00 $3,057 D/D 50,427 126,870     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-12-30 4 S $7.37 $40,682 D/D (5,520) 126,443     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-12-30 4 D $7.16 $666 D/D (93) 121,352     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-12-30 4 A $7.16 $3,408 D/D 476 121,445     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-12-30 4 D $7.16 $1,375 D/D (192) 295,622     -
  586 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us